Literature DB >> 14730325

Diurnal blood pressure variation in pheochromocytoma, primary aldosteronism and Cushing's syndrome.

T Zelinka1, B Strauch, L Pecen, J Widimský.   

Abstract

We examined circadian blood pressure (BP) variation (expressed as a relative night-time BP decline) in subjects with primary aldosteronism (78 patients), pheochromocytoma (n=45) and Cushing's syndrome (n=18). Subjects with aldosterone-producing adenoma (n=21) and pheochromocytoma (n=27) were also investigated after the tumour removal. In all, 65 patients with essential hypertension served as a control group. The night-time BP decline was significantly attenuated in all three forms of endocrine hypertension compared to the control group (primary aldosteronism P<0.0001, pheochromocytoma P<0.0001 for systolic and diastolic BP and Cushing's syndrome P<0.0001/<0.001 vs essential hypertension). In the case of pheochromocytoma, the absence of the night-time BP decrease was more prominent compared to the primary aldosteronism group (P=0.003/0.001) and for the diastolic BP also in comparison with the Cushing's syndrome group (P=0.03). Tumour removal led in both groups to the restoration of the previously altered circadian rhythm (aldosterone-producing adenoma: P=0.0005/0.0009; pheochromocytoma: P=0.001/0.0007). Our study demonstrates a blunted circadian BP variation in all forms of adrenal hypertension in comparison with essential hypertension. This reduction of the night-time BP decrease was more prominent in pheochromocytoma than in primary aldosteronism or Cushing's syndrome.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14730325     DOI: 10.1038/sj.jhh.1001644

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  11 in total

1.  Circadian blood pressure profile in patients with Cushing's syndrome before and after treatment.

Authors:  S Zacharieva; M Orbetzova; A Stoynev; R Shigarminova; M Yaneva; K Kalinov; E Nachev; A Elenkova
Journal:  J Endocrinol Invest       Date:  2004-11       Impact factor: 4.256

Review 2.  Endocrine Tumors Causing Arterial Hypertension: Pathophysiological Mechanisms and Clinical Implications.

Authors:  Agata Buonacera; Benedetta Stancanelli; Lorenzo Malatino
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-04-12

3.  The platelet-to-lymphocyte ratio as an inflammation marker in non-dipper hypertensive patients.

Authors:  N Bayrakci; N Ozkayar; F Akyel; I Ates; S Akyel; F Dede
Journal:  Hippokratia       Date:  2015 Apr-Jun       Impact factor: 0.471

Review 4.  Glucocorticoid excess and hypertension.

Authors:  Smita Baid; Lynnette K Nieman
Journal:  Curr Hypertens Rep       Date:  2004-12       Impact factor: 5.369

5.  Prevalence and clinical characteristics of primary aldosteronism in a tertiary-care center in Korea.

Authors:  Minjae Yoon; Namki Hong; Jaehyung Ha; Chan Joo Lee; Cheol Ryong Ku; Yumie Rhee; Sungha Park
Journal:  Hypertens Res       Date:  2022-06-09       Impact factor: 5.528

6.  A critical role for vascular smooth muscle in acute glucocorticoid-induced hypertension.

Authors:  Julie E Goodwin; Junhui Zhang; David S Geller
Journal:  J Am Soc Nephrol       Date:  2008-04-23       Impact factor: 10.121

7.  Cardiovascular autonomic function in Cushing's syndrome.

Authors:  F Fallo; P Maffei; A Dalla Pozza; M Carli; P Della Mea; M Lupia; F Rabbia; N Sonino
Journal:  J Endocrinol Invest       Date:  2009-01       Impact factor: 4.256

8.  Ambulatory blood pressure monitoring in secondary arterial hypertension due to adrenal diseases.

Authors:  Michele Ceruti; Luigi Petramala; Dario Cotesta; Sabrina Cerci; Valentina Serra; Chiara Caliumi; Monica Iorio; Giorgio De Toma; Antonio Ciardi; Domenico Vitolo; Claudio Letizia
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-09       Impact factor: 3.738

Review 9.  Circadian Regulation of Blood Pressure: of Mice and Men.

Authors:  Megan K Rhoads; Vikhram Balagee; S Justin Thomas
Journal:  Curr Hypertens Rep       Date:  2020-05-21       Impact factor: 4.592

Review 10.  Circadian Clock, Cell Division, and Cancer: From Molecules to Organism.

Authors:  Anton Shostak
Journal:  Int J Mol Sci       Date:  2017-04-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.